高视医疗科技有限公司（02407）8月3日发布补充公告称，基于对截至2026年6月30日止六个月未经过审的综合管理账目的初步审阅，预计该期收入约为5.83亿至6.07亿元，较2025年同期的约6.53亿元减少约7.1%至10.7%。\n\n公司表示，业绩变动的主要原因与7月23日已公布的盈利警告公告所述因素一致。除本次补充信息外，原盈利警告公告的其他内容保持不变。\n\n高视医疗指出，目前仍在编制2026年中期业绩，相关财务数据尚未经核数师或审计委员会审核。公司预计将于2026年8月底披露完整的中期业绩报告。\n\n公司提醒投资者审慎决策。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.